CN Stock MarketDetailed Quotes

Xiamen Amoytop Biotech (688278)

Watchlist
  • 75.90
  • -0.28-0.37%
Market Closed Jan 16 15:00 CST
30.98BMarket Cap32.97P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xiamen Amoytop Biotech (688278) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Main business1.51B99.66%
Other business5.18M0.34%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Biological agent2.81B99.73%
Other business7.75M0.27%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
East China921.29M32.70%
Southwest448.52M15.92%
Central China408.76M14.51%
North China390.05M13.85%
South China306.4M10.88%
Northwest233.14M8.28%
Northeast China97.59M3.46%
Other business7.75M0.27%
Overseas3.66M0.13%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.22%
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +2.85%
4
Block
XYZ
+1.59%
5
Microsoft
MSFT
+1.27%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -